https://arolstar52-zhtest.hf.space/index.php?action=history&feed=atom&title=ADB-P7AICA
ADB-P7AICA - 版本历史
2026-07-15T17:09:34Z
在这个wiki上该页的修订历史
MediaWiki 1.43.9
https://arolstar52-zhtest.hf.space/index.php?title=ADB-P7AICA&diff=4345705&oldid=prev
imported>Jimmy-bot：机器人: 尚未清空的已重定向分类） （Cat:狡詐家藥物→Cat:策划药
2025-08-15T10:22:39Z
<p>机器人: 尚未清空的已重定向分类） （<a href="/index.php?title=Cat:%E7%8B%A1%E8%A9%90%E5%AE%B6%E8%97%A5%E7%89%A9&action=edit&redlink=1" class="new" title="Cat:狡詐家藥物（页面不存在）">Cat:狡詐家藥物</a>→<a href="/index.php?title=Cat:%E7%AD%96%E5%88%92%E8%8D%AF&action=edit&redlink=1" class="new" title="Cat:策划药（页面不存在）">Cat:策划药</a></p>
<p><b>新页面</b></p><div>{{Drugbox<br />
| IUPAC_name = ''N''-[(2''S'')-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-pentylpyrrolo[2,3-b]pyridine-3-carboxamide<br />
| image = ADB-P7AICA_structure.png<br />
| synonyms = (''S'')–''N''-(1-氨基-3,3-二甲基-1-氧代丁-2-基)-1-戊基-1''H''-吡咯并[2,3-''b'']吡啶-3-甲酰胺<br>''N''-[(1''S'')-1-(氨基羰基)-2,2-二甲基丙基]-1-戊基-1''H''-吡咯并[2,3-''b'']吡啶-3-甲酰胺<br />
<br />
<!--Clinical data--><br />
| tradename = <br />
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --><br />
| pregnancy_US = <!-- A / B / C / D / X --><br />
| pregnancy_category = <br />
| legal_AU = <br />
| legal_DE = NpSG<br />
| legal_UK = Class B<br />
| legal_US = <br />
| legal_status = <br />
| routes_of_administration =<br />
<br />
<!--Pharmacokinetic data--><br />
| bioavailability = <br />
| protein_bound = <br />
| metabolism = <br />
| elimination_half-life = <br />
| excretion =<br />
<br />
<!--Identifiers--><br />
| CAS_number = 2366273-07-4<br />
| CAS_number_Ref = {{cascite|correct|CAS}}<br />
| UNII = <br />
| ATC_prefix = <br />
| ATC_suffix = <br />
| PubChem = 155538637<br />
| ChemSpiderID = 109117928<br />
| smiles = NC(=O)[C@@H](NC(=O)c1cn(CCCCC)c2ncccc21)C(C)(C)C<br />
| StdInChI = 1S/C19H28N4O2/c1-5-6-7-11-23-12-14(13-9-8-10-21-17(13)23)18(25)22-15(16(20)24)19(2,3)4/h8-10,12,15H,5-7,11H2,1-4H3,(H2,20,24)(H,22,25)/t15-/m1/s1<br />
| StdInChIKey = QDZHLYBDQFZWCJ-OAHLLOKOSA-N<br />
<br />
<!--Chemical data--><br />
| C=19 | H=28 | N=4 | O=2<br />
| melting_point = 90.1<br />
| melting_high = 94.3<br />
| melting_notes = <ref name=Moir>Strategies to develop selective CB2 receptor agonists from indole carboxamide synthetic cannabinoids. ''European Journal of Medicinal Chemistry'', 2019. {{doi|10.1016/j.ejmech.2019.07.036}}.</ref><br />
}}<br />
<br />
'''ADB-P7AICA'''（分子式：[[C19H28N4O2|C<sub>19</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub>]]）是一种具有[[大麻素]]结构的[[狡詐家藥物]]，为白色固体，它是一些{{le|合成大麻|synthetic cannabis}}产品的成分，[[美国缉毒局]]在2021年检出了该物质。<ref>[https://www.deadiversion.usdoj.gov/dea_tox/ADB-P7AICA.pdf Announcement of a Newly Identified Synthetic Cannabinoid ADB-P7AICA – February 25, 2021. Drug Enforcement Administration Toxicology Testing Program]</ref>它可以[[吡咯并［2,3-b］吡啶|吡咯并[2,3-''b'']吡啶]]和[[1,5-戊二醇]]为原料经多步反应制得。<ref name=Moir /><br />
<br />
== 参考文献 ==<br />
{{reflist}}<br />
<br />
{{大麻素}}<br />
<br />
[[Category:大麻素]]<br />
[[Category:策划药]]<br />
[[Category:正戊基化合物]]<br />
[[Category:叔丁基化合物]]</div>
imported>Jimmy-bot